California State Teachers Retirement System (CalSTRS)’s Cyclerion Therapeutics CYCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,676
Closed -$94K 3124
2021
Q1
$94K Hold
1,676
﹤0.01% 3048
2020
Q4
$103K Hold
1,676
﹤0.01% 3005
2020
Q3
$204K Sell
1,676
-185
-10% -$21.2K ﹤0.01% 2703
2020
Q2
$220K Hold
1,861
﹤0.01% 2665
2020
Q1
$99K Buy
1,861
+21
+1% +$1.5K ﹤0.01% 2816
2019
Q4
$100K Hold
1,840
﹤0.01% 2925
2019
Q3
$446K Buy
1,840
+22
+1% +$4.75K ﹤0.01% 2367
2019
Q2
$416K Buy
+1,818
New +$515K ﹤0.01% 2463

Other funds holding CYCN

California State Teachers Retirement System (CalSTRS)'s CYCN Position: Q2 2021 in Review

California State Teachers Retirement System (CalSTRS) sold out of Cyclerion Therapeutics (CYCN) in Q2 2021, closing a stake of 1,676 shares — an estimated $94K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in CYCN in Q2 2019 and held it in 8 quarters. The position peaked at $446K in Q3 2019. 67 funds tracked by Wall St. Rank hold CYCN as of Q2 2021.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Cyclerion Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 1,676 Cyclerion Therapeutics shares in Q2 2021, an estimated $94K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Cyclerion Therapeutics in Q2 2019 and held it in 8 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Cyclerion Therapeutics position peaked at $446K in Q3 2019.
  • 67 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q2 2021.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2021, filed 16 Aug 2021.